RA Capital Management, L.P., Director, 10% Owner at Artiva Biotherapeutics, Inc. (ARTV), bought 41,319 shares at $9.99 ($413K) on 2026-07-24, disclosed to the SEC on 2026-07-28.
Open-market purchase of $413k ARTV by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| ARTV | BUY | 2026-07-31 | $456K | — | Filing → |
| ARTV | BUY | 2026-07-23 | $58K | — | Filing → |
| ARTV | BUY | 2026-07-23 | $2.6M | — | Filing → |